Trends in First Tier Biotech In-Licensing
Executive Summary
In terms of total in-licensing dollar volume, first-tier biotechs (defined as biotechs with a cap over $1 billion) aren't in the same league as Big Pharma (the top 20 pharmaceutical companies ranked by worldwide sales)--but that's slowly and steadily changing.